Association of clonal hematopoiesis of indeterminate potential with myocardial characteristic differences in

Jooyeon Lee1, Yoo Jin Hong2, Jin-Ho Park3

  • 1Division of Cardiology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Republic of Korea.

Heliyon
|March 14, 2025
PubMed

Insights

Clonal hematopoiesis (CHIP) is linked to altered heart tissue in non-ischemic heart failure (HF) patients. While CHIP affects cardiac MRI findings, its short-term impact on heart remodeling in HF is not significant.

Area of Science:

  • Cardiology
  • Genetics
  • Aging

Background:

  • Clonal hematopoiesis of indeterminate potential (CHIP) is an aging-related process impacting heart failure (HF) prognosis.
  • CHIP's association with myocardial characteristics in non-ischemic HF requires further investigation.

Purpose of the Study:

  • To investigate the relationship between CHIP and myocardial tissue characteristics using cardiac MRI in non-ischemic HF patients.
  • To assess the impact of CHIP on left ventricular reverse remodeling in this patient cohort.

Main Methods:

  • Cardiac MRI (including T1, extracellular volume, and late gadolinium enhancement) and next-generation sequencing for CHIP mutations were performed on 95 non-ischemic HF patients.
  • Transthoracic echocardiography assessed left ventricular reverse remodeling.

Main Results:

  • CHIP was identified in 15 patients, who exhibited higher native T1, extracellular volume fraction, and late gadolinium enhancement (LGE) on cardiac MRI.
  • CHIP mutations independently correlated with cardiac MRI mapping values.
  • No significant difference in left ventricular reverse remodeling was observed between CHIP-positive and CHIP-negative patients within one year.

Conclusions:

  • CHIP is associated with distinct myocardial tissue characteristics, including increased mapping values and LGE, in non-ischemic HF.
  • The short-term effect of CHIP on left ventricular reverse remodeling in non-ischemic HF appears attenuated.
  • Further research is warranted to understand the long-term implications of CHIP in heart failure.